HTN Drug Info + Tx Flashcards
First line HTN and late line TxofC
Thiazides
Calcium channel blockers
ACE
ARBs
Heart failure HTN tx
Ace inhibitor or ARB + beta blocker + diuretic + aldosterone antagonist
Try to get all four to lower mortality risk
Post-MI HTN tx
Beta blocker + ACE inhibitor or ARB
Try to get both
High coronary disease risk
HTN Tx
Beta blocker
ACE inhibitor or ARB
CCB or thiazides
Diabetes
HTN Tx
ACE inhibitor or ARB then CCB or thiazides
CKD HTN Tex
Ace inhibitor or ARB
Then CCB or thiazides
Recurrent stroke prevention HTN tx
Ace inhibitor or ARB
Then thiazides or CCB
Pregnancy and HTN tx options
NO ACE or ARB
Can use thiazides, CCB, or Beta blocker
If > 80 yrs w/risk of gout, urinary incontinence, SSRI rx or low serum Na
Avoid which ones?
No thiazides
Only ACE, CCB, ARB
Diuretics general classes
Thiazides
Loop
Potassium sparing
Diuretics general MOA
Decrease ability of kidneys to reabsorb water
Temporarily lower blood volume then it works to anti HTN
more effective when combined with ACEI/ARB
Thiazides
Dose and MOA
Dose in morning to avoid nocturia
Increased renal excretion of sodium, may vasodilator
Thiazides ADRs
Electrolyte abnormalities
Gout
Hyperglycemia (caution in DM)
Hypovolemia
specific electrolyte abnormalities associated with Thiazides
hyponatremia
hypokalemia
hypomagnesemia
hypercalcemia
contraction alkalosis
what should you do w/in 10-14 days of initiation on a thiazide
electrolyte panel
checks for hypokalemia and hyponatremia
loop diuretic dosage
dose in AM or afternoon
higher doses may be needed for decreased GFR (CKD pos), accustomed to med, or heart failure
loop diuretics ADRs
hyponatremia, hypokalemia, hypomagnesemia, hypOcalcemia
hyperuricemia
hyperglycemia
potassium sparing diuretics
Dose in AM or afternoon
weak so typically used as add on to prevent hypokalemia
ADRs potassium sparing diuretics
hyperkalemia (esp. in combo with ACE, ARB or K + supplement)
avoid in patients with DM or CKD
Aldosterone antagonists ADRs
hyperkalmia
avoid in CKD/DM
gynecomastia and impotence
ACE inhibitors TOC
HTN, CKD, and proteinuria
reduced morbidity and mortality in heart failure and recent MI
ACE I. MOA
blocks conversion of angiotensin II = vasodilation
blocks RAAS activation
inhibits bradykinin breakdown (vasodilation)
monitoring with ACE I
monitor serum K+ and Cr w/in 2 weeks of ignition or dose increasing
ACE I ADRs
dry cough (bc increased bradykinin)
angioedema
hyperkalemia
CI in pregnancy